Finn Burg

Finn Burg is an accomplished scientific leader currently serving as Laboratory Head - Process R&D at Bayer since July 2022, overseeing an organic synthesis laboratory focused on developing optimal synthetic routes for active pharmaceutical ingredients with an emphasis on scalability and sustainability. Prior to this role, Finn held positions at prestigious institutions including Columbia University as a Feodor Lynen Postdoctoral Fellow, where research projects centered on Rh(III) and Ir(III) catalysis, and at the Technical University of Munich as a Postdoctoral Scientist and PhD student, contributing significant advancements in enantioselective catalysis. Early career experiences include a research scholar role at Harvard University, and earlier contributions to Bayer as a research associate. Educational qualifications include a Doctor of Philosophy in Organic Chemistry from the Technical University of Munich and further advanced studies at Columbia University and Harvard University.